scispace - formally typeset
G

Gunjan Kumar

Researcher at Indian Council of Medical Research

Publications -  46
Citations -  920

Gunjan Kumar is an academic researcher from Indian Council of Medical Research. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 5, co-authored 25 publications receiving 505 citations. Previous affiliations of Gunjan Kumar include Jawaharlal Institute of Postgraduate Medical Education and Research & Lady Hardinge Medical College.

Papers
More filters
Journal ArticleDOI

Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial).

TL;DR: This trial has high generalisability and approximates convalescent plasma use in real life settings with limited laboratory capacity and was not associated with a reduction in progression to severe covid-19 or all cause mortality.
Journal ArticleDOI

Utilisation, equity and determinants of full antenatal care in India: analysis from the National Family Health Survey 4

TL;DR: Although half of the women did not receive the minimum recommended ANC visits, the utilisation of TT immunisation was almost universal and the positive association of full ANC with ICDS utilisation and child’s father involvement may be leveraged for increasing the uptake of fullANC.
Posted ContentDOI

Convalescent plasma in the management of moderate COVID-19 in India: An open-label parallel-arm phase II multicentre randomized controlled trial (PLACID Trial)

Anup Agarwal, +261 more
- 08 Sep 2020 - 
TL;DR: This trial has high generalizability and approximates real-life setting of CP therapy in settings with limited laboratory capacity and a priori measurement of neutralizing antibody titres in donors and participants may further clarify the role of CP in management of COVID-19.
Journal ArticleDOI

Clinical profile of hospitalized COVID-19 patients in first & second wave of the pandemic: Insights from an Indian registry based observational study.

TL;DR: The second wave of COVID-19 in India was slightly different in presentation than the first wave, with a younger demography, lesser comorbidities, and presentation with breathlessness in greater frequency as mentioned in this paper.